1 109 134 A PILOT STUDY ASSESSING ACCEPTABILITY AND FEASIBILITY OF HATHA YOGA FOR CHRONIC PAIN IN PEOPLE RECEIVING OPIOID AGONIST THERAPY FOR OPIOID USE DISORDER. THE PURPOSE OF THIS PROJECT WAS TO ASSESS THE FEASIBILITY AND ACCEPTABILITY OF A HATHA YOGA PROGRAM DESIGNED TO TARGET CHRONIC PAIN IN PEOPLE RECEIVING OPIOID AGONIST THERAPY FOR OPIOID USE DISORDER. WE CONDUCTED A PILOT RANDOMIZED TRIAL IN WHICH PEOPLE WITH CHRONIC PAIN WHO WERE RECEIVING EITHER METHADONE MAINTENANCE THERAPY (N=20) OR BUPRENORPHINE (N=20) WERE RANDOMLY ASSIGNED TO WEEKLY HATHA YOGA OR HEALTH EDUCATION (HE) CLASSES FOR 3MONTHS. WE DEMONSTRATED FEASIBILITY IN MANY DOMAINS, INCLUDING RECRUITMENT OF PARTICIPANTS (58% FEMALE, MEAN AGE 43), RETENTION FOR FOLLOW-UP ASSESSMENTS, AND ABILITY OF TEACHERS TO PROVIDE INTERVENTIONS WITH HIGH FIDELITY TO THE MANUALS. FIFTY PERCENT OF PARTICIPANTS IN YOGA (95% CI: 0.28-0.72) AND 65% OF PARTICIPANTS IN HE (95% CI: 0.44-0.87) ATTENDED AT LEAST 6 OF 12 POSSIBLE CLASSES (P=0.62). SIXTY-ONE PERCENT IN THE YOGA GROUP REPORTED PRACTICING YOGA AT HOME, WITH A MEAN NUMBER OF TIMES PRACTICING PER WEEK OF 2.67 (SD=2.37). PARTICIPANT MOOD IMPROVED PRE-CLASS TO POST-CLASS, WITH GREATER DECREASES IN ANXIETY AND PAIN FOR THOSE IN THE YOGA GROUP (P<0.05). IN CONCLUSION, YOGA CAN BE DELIVERED ON-SITE AT OPIOID AGONIST TREATMENT PROGRAMS WITH HOME PRACTICE TAKEN UP BY THE MAJORITY OF PARTICIPANTS. FUTURE RESEARCH MAY EXPLORE WAYS OF INCREASING THE YOGA "DOSAGE" RECEIVED. THIS MAY INVOLVE TESTING STRATEGIES FOR INCREASING EITHER CLASS ATTENDANCE OR THE AMOUNT OF HOME PRACTICE OR BOTH. 2019 2 2475 27 YOGA AS AN ADJUNCT FOR MANAGEMENT OF OPIOID DEPENDENCE SYNDROME: A NINE-MONTH FOLLOW-UP CASE REPORT. OPIOID DEPENDENCE SYNDROME (ODS) IS A CHRONIC RELAPSING REMITTING CONDITION ASSOCIATED WITH SIGNIFICANT IMPAIRMENT AND MORTALITY RISK. OPIOID SUBSTITUTION THERAPY IS USED WORLDWIDE, BUT LONG-TERM RETENTION RATES ARE LOW AND THERE IS RISK OF MISUSE AND DIVERSION. YOGA PRACTICE CAN IMPROVE QUALITY OF LIFE, REDUCE CHRONIC PAIN, AND ENHANCE ENDOGENOUS OPIOIDS (BETA-ENDORPHINS). WE DESCRIBE A CASE OF ODS WHERE YOGA WAS ADDED TO THE CONVENTIONAL MANAGEMENT AND WHO WAS FOLLOWED UP FOR 9 MONTHS. ASSESSMENTS WERE DONE FOR CLINICAL SYMPTOMS, URINE DRUG SCREENING, PLASMA BETA-ENDORPHINS, AND BUPRENORPHINE DOSAGE. WE OBSERVED AN IMPROVEMENT IN HIS CLINICAL SYMPTOMS AND REDUCTION IN THE REQUIREMENTS FOR BUPRENORPHINE. A SLIGHT INCREASE IN BASAL PLASMA BETA-ENDORPHIN LEVELS WAS ALSO OBSERVED AT THE 9-MONTH FOLLOW-UP (FROM 2.02 PMOL/L AT BASELINE TO 6.51 PMOL/L). 2021 3 2477 39 YOGA AS AN ADJUNCTIVE INTERVENTION TO MEDICATION-ASSISTED TREATMENT WITH BUPRENORPHINE+NALOXONE. OBJECTIVE: ACCORDING TO THE CDC, 2.6 MILLION PEOPLE IN THE UNITED STATES HAVE AN OPIOID USE DISORDER AND DRUG OVERDOSE IS THE LEADING CAUSE OF ACCIDENTAL DEATH. OPIOIDS ARE INVOLVED IN 63% OF OVERDOSE DEATHS. IT IS IMPERATIVE THAT WE IDENTIFY EVIDENCE BASED TREATMENTS TO STEM THE TIDE OF THIS EPIDEMIC. THIS PILOT STUDY SERVES TO EXPLORE THE FEASIBILITY AND EFFECTIVENESS OF YOGA AS AN ADJUNCTIVE INTERVENTION FOR INDIVIDUALS WITH OPIOID USE DISORDER IN ACTIVE MEDICATION-ASSISTED TREATMENT (MAT). METHODS: PARTICIPANTS (N=26) WERE RECRUITED FROM A BUPRENORPHINE/NALOXONE MAT PROGRAM TO PARTICIPATE IN THIS STUDY. 13 PARTICIPANTS ENGAGED IN A 12 WEEK ADJUNCTIVE YOGA INTERVENTION WHILE REMAINING IN TREATMENT AS USUAL (TAU) MAT. 13 MATCHED CONTROLS WERE RECRUITED AND REMAINED IN TAU MAT. BOTH GROUPS WERE EVALUATED AT BASELINE, 45 DAYS AND 90 DAYS FOR CHANGES IN CRAVING FOR OPIOIDS, TREATMENT RETENTION, RELAPSE RATES, SLEEP, AND SYMPTOMS OF ANXIETY AND PERCEIVED STRESS. RESULTS: A TWO-WAY TREATMENT BY TIME ANALYSIS OF VARIANCE WAS PERFORMED USING A MIXED EFFECTS MODEL. THE TREATMENT BY FOLLOW-UP TIME INTERACTION EFFECT WAS SIGNIFICANT FOR PERCEIVED STRESS (P=0.026) INDICATING THAT THE YOGA INTERVENTION HAD A LARGER EFFECT THAN TAU (MAT). CHANGES IN PERCEIVED STRESS DECREASED SIGNIFICANTLY OVER TIME IN BOTH THE YOGA INTERVENTION GROUP AND THE TAU MAT MATCHED CONTROL GROUP. CONCLUSION: THIS PILOT STUDY INDICATED STRONG EVIDENCE FOR YOGA BEING AN EFFECTIVE ADJUNCTIVE TREATMENT TO MAT TAU IN REDUCING PERCEIVED STRESS. FURTHER RESEARCH WITH A LARGER POPULATION IS NEEDED TO DETERMINE IMPACT ON OTHER MENTAL HEALTH SYMPTOMS AND RELAPSE AND RETENTION RATES. 2018 4 622 45 DEVELOPMENT, VALIDATION, AND FEASIBILITY TESTING OF A YOGA MODULE FOR OPIOID USE DISORDER. CONTEXT: OPIOID USE DISORDER (OUD) INVOLVES EXCESSIVE USE OF OPIOIDS-SUCH AS HEROIN, MORPHINE, FENTANYL, CODEINE, OXYCODONE, AND HYDROCODONE-LEADING TO MAJOR HEALTH, SOCIAL, AND ECONOMIC CONSEQUENCES. YOGA LIFESTYLE INTERVENTIONS HAVE BEEN FOUND TO BE USEFUL AS ADJUNCT THERAPIES IN MANAGEMENT OF SUBSTANCE USE DISORDERS AND CHRONIC PAIN CONDITIONS. OBJECTIVE: THE RESEARCH TEAM INTENDED TO DEVELOP, VALIDATE, AND TEST FOR FEASIBILITY A YOGA PROGRAM FOR OUD PATIENTS THAT COULD REDUCE OPIATE WITHDRAWAL SYMPTOMS-SUCH AS PAIN, FATIGUE, LOW MOOD, ANXIETY AND SLEEP DISTURBANCES-AND CRAVINGS ASSOCIATED WITH DRUGS. DESIGN: THE RESEARCH TEAM FIRST PERFORMED A LITERATURE REVIEW OF TRADITIONAL AND CONTEMPORARY YOGA TEXTS, SUCH AS HATHA YOGA PRADIPIKA AND LIGHT ON YOGA, AS WELL AS MODERN SCIENTIFIC LITERATURE IN THE FOLLOWING SEARCH ENGINES-GOOGLE SCHOLAR, PUBMED, AND PSYCHINFO, USING THE KEYWORDS YOGA, PRANAYAMA, HATHA YOGA, RELAXATION. MEDITATION, SUBSTANCE USE, ADDICTION, IMPULSIVITY, CRAVING, SLEEP QUALITY, AND FATIGUE. USING THE INFORMATION OBTAINED, THE TEAM DEVELOPED A YOGA PROGRAM AND DESIGNED A PILOT STUDY THAT USED THE PROGRAM. SETTING: THE STUDY TOOK PLACE IN THE DEPARTMENT OF INTEGRATIVE MEDICINE AT THE NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES (NIMHANS) IN BANGALORE, INDIA. PARTICIPANTS: PARTICIPANTS IN THE PILOT STUDY WERE 8 INPATIENTS, 6 MALES AND 2 FEMALES, WHO WERE ON OPIOID AGONIST TREATMENT (BUPRENORPHINE) FOR OUD. INTERVENTION: THE INTERVENTION WAS THE YOGA PROGRAM PREVIOUSLY VALIDATED BY THE RESEARCH TEAM. IN THE PILOT STUDY, PARTICIPANTS WERE TAUGHT A ONE-HOUR, YOGA-BASED INTERVENTION, WITH SESSIONS OCCURRING ONCE PER DAY, FOR 10 SESSIONS. OUTCOME MEASURES: FOR VALIDATION, 13 EXPERTS SCORED THE YOGA PROGRAM THAT THE RESEARCH TEAM HAD DEVELOPED AND GAVE SUGGESTIONS FOR EACH YOGIC PRACTICE FOR USE DURING THE ACUTE PHASE OF WITHDRAWAL AND THE MAINTENANCE PHASE RESPECTIVELY. A CONTENT VALIDITY RATIO (CVR) WAS CALCULATED FROM THEIR SCORING, AND THE RESEARCH TEAM MADE CHANGES TO THE PROGRAM BASE ON THE SCORING AND SUGGESTIONS. FOR THE PILOT STUDY, ASSESSMENTS OCCURRED AT BASELINE AND POSTINTERVENTION. THE PARTICIPANTS' YOGA PERFORMANCE WAS RATED BY THE YOGA TRAINER ON A YOGA PERFORMANCE ASSESSMENT SCALE (YPA). OTHER MEASUREMENTS INCLUDED: (1) THE CLINICAL OPIATE WITHDRAWAL SCALE (COWS), (2) THE HAMILTON'S ANXIETY RATING SCALE (HAM-A), (3) THE HAMILTON'S DEPRESSION RATING SCALE (HAM-D), (4) BUPRENORPHINE DOSAGE, (5) THE CLINICAL GLOBAL IMPRESSION SEVERITY (CGI-S) SCALE, (6) A VISUAL ANALOG SCALE (VAS) FOR PAIN, (7) SLEEP QUALITY (LATENCY AND DURATION), AND (8) THE MODULE'S SAFETY. RESULTS: FOUR PRACTICES WERE REMOVED FROM THE PROGRAM DUE TO CVR SCORES BELOW THE CUTOFF, AND ONE PRACTICE WAS FOUND NOT TO BE FEASIBLE (KAPALABHATI). TWO CATEGORIES OF YOGA MODULES EMERGED: (1) FOR THE ACUTE SYMPTOMATIC PHASE (40 MINUTES) AND (2) FOR THE MAINTENANCE PHASE (ONE HOUR). PRACTICES WERE ADDED OR EXCLUDED BASED ON THE PHASE. CONCLUSIONS: THE YOGA MODULE THAT WAS DEVELOPED FOR REDUCING WITHDRAWAL SYMPTOMS AND CRAVINGS IN OUD PATIENTS WAS FOUND TO BE SAFE, FEASIBLE, AND POTENTIALLY USEFUL AS AN ADJUNCT THERAPY TO CONVENTIONAL TREATMENT. 2021 5 1851 28 RAJA YOGA MEDITATION AND MEDICATION-ASSISTED TREATMENT FOR RELAPSE PREVENTION: A PILOT STUDY. THE CONTINUED NEED FOR ADVANCEMENT IN EVIDENCE-BASED SUD TREATMENT, AS WELL AS INCREASES IN TREATMENT EXPENSE AND DECLINE IN SUPPORT FROM INSURANCE PROVIDERS, SUGGEST THAT BRIEF, INNOVATIVE, AND AFFORDABLE TREATMENTS ARE NEEDED. MEDITATION, SPIRITUALITY, AND ADHERENCE TO MEDICATION-ASSISTED TREATMENTS HAVE ALL BEEN SHOWN TO SUPPORT ABSTINENCE. THE CURRENT TRIAL ASSESSED EFFECTS OF SPIRITUALLY-BASED MEDITATION, VERSUS RELAXATION OR STANDARD TREATMENT, ON SUBSTANCE ABSTINENCE AND PSYCHOLOGICAL DISTRESS AND DYSFUNCTION IN A PARTIALLY BUPRENORPHINE-SUPPORTED (41.5%) TREATMENT SAMPLE. PARTICIPANTS (N=40) WERE RECRUITED FROM AN INTENSIVE OUTPATIENT TREATMENT PROGRAM, IN WHICH THREE TREATMENT LOCATIONS ACTED AS SEPARATE EXPERIMENTAL CONDITIONS. ABSTINENCE WAS MEASURED THROUGH URINALYSES AT BASELINE AND WEEKLY THEREAFTER FOR THE DURATION OF THE INTERVENTION. PSYCHOLOGICAL DISTRESS AND DYSFUNCTION WERE ASSESSED WITH A LIKERT-SCALED QUESTIONNAIRE MEASURING SYMPTOMS TYPICALLY ASSOCIATED WITH SUD. CO-VARYING FOR BUPRENORPHINE USE, PARTICIPANTS IN THE MEDITATION CONDITION HAD BETTER ODDS OF REMAINING ABSTINENT THAN PARTICIPANTS IN THE TREATMENT-AS-USUAL (TAU) AND RELAXATION CONDITIONS. THERE WERE NO SIGNIFICANT DIFFERENCES IN SUBSTANCE ABSTINENCE BETWEEN THE RELAXATION AND TAU CONDITIONS. FURTHER, CO-VARYING OUT BASELINE THERE WERE NO SIGNIFICANT DIFFERENCES AT POST-COURSE IN PSYCHOLOGICAL DISTRESS AND DYSFUNCTION BETWEEN THE THREE CONDITIONS. RESULTS FROM THIS PILOT TRIAL SUGGEST THAT THIS SPIRITUALLY-INFORMED APPROACH MAY OFFER ADDITIVE SUPPORT TO INDIVIDUALS IN SUD TREATMENT, AS AN AID TO THE MEDITATIVE ASPECT OF THE 12 STEPS, OR A NON-12-STEP ALTERNATIVE SPIRITUAL SUPPLEMENT TO STANDARD SUD TREATMENT. 2019 6 517 41 COMPARING HATHA YOGA WITH DYNAMIC GROUP PSYCHOTHERAPY FOR ENHANCING METHADONE MAINTENANCE TREATMENT: A RANDOMIZED CLINICAL TRIAL. BACKGROUND: AS MORE METHADONE TREATMENT PROGRAMS ARE FUNDED IN AN ATTEMPT TO CURB SUBSTANCE ABUSE AND HIV INFECTION AMONG I.V. DRUG USERS, MORE COST EFFECTIVE TREATMENT APPROACHES ARE BEING SOUGHT. OBJECTIVES: TO INVESTIGATE WHETHER CLIENTS IN OUTPATIENT METHADONE MAINTENANCE TREATMENT WHO PRACTICE WEEKLY HATHA YOGA IN A GROUP SETTING EXPERIENCE MORE FAVORABLE TREATMENT OUTCOMES THAN THOSE WHO RECEIVE CONVENTIONAL GROUP PSYCHODYNAMIC THERAPY. METHODS: AFTER A 5-DAY ASSESSMENT PERIOD, 61 PATIENTS WERE RANDOMLY ASSIGNED TO METHADONE MAINTENANCE ENHANCED BY TRADITIONAL GROUP PSYCHOTHERAPY (IE, CONVENTIONAL METHADONE TREATMENT) OR AN ALTERNATIVE HATHA YOGA THERAPY (IE, ALTERNATIVE METHADONE TREATMENT). PATIENTS WERE FOLLOWED FOR 6 MONTHS AND EVALUATED ON A VARIETY OF PSYCHOLOGICAL, SOCIOLOGICAL, AND BIOLOGICAL MEASURES. THE REVISED SYMPTOM CHECK LIST PROVIDED THE PRIMARY PSYCHOLOGICAL MEASURES; THE ADDICTION SEVERITY INDEX PROVIDED VARIOUS INDICES OF ADDICTIVE BEHAVIORS. RESULTS: THE EVIDENCE REVEALED THAT THERE WERE NO MEANINGFUL DIFFERENCES BETWEEN TRADITIONAL PSYCHODYNAMIC GROUP THERAPY AND HATHA YOGA PRESENTED IN A GROUP SETTING. BOTH TREATMENTS CONTRIBUTED TO A TREATMENT REGIMEN THAT SIGNIFICANTLY REDUCED DRUG USE AND CRIMINAL ACTIVITIES. PSYCHOPATHOLOGY AT ADMISSION WAS SIGNIFICANTLY RELATED TO PROGRAM PARTICIPATION REGARDLESS OF TREATMENT GROUP. DISCUSSION: IN ADDITION TO EXAMINING THE CHARACTERISTICS OF PATIENTS WHO PRESENT FOR TREATMENT, THIS STUDY IDENTIFIES UNEXPECTED STAFF ISSUES THAT COMPLICATE THE INTEGRATION OF ALTERNATIVE AND TRADITIONAL TREATMENT STRATEGIES. CONCLUSION: ALTERNATIVE METHADONE TREATMENT IS NOT MORE EFFECTIVE THAN CONVENTIONAL METHADONE TREATMENT, AS ORIGINALLY HYPOTHESIZED. HOWEVER, SOME PATIENTS MAY BENEFIT MORE FROM ALTERNATIVE METHADONE TREATMENT THAN CONVENTIONAL METHADONE TREATMENT. ADDITIONAL RESEARCH IS NECESSARY TO DETERMINE CHARACTERISTICS THAT IDENTIFY PATIENTS WHO MIGHT BENEFIT FROM ALTERNATIVE METHADONE TREATMENT. 1997 7 1663 28 NATURALISTIC EVALUATION OF AN ADJUNCTIVE YOGA PROGRAM FOR WOMEN WITH SUBSTANCE USE DISORDERS IN INPATIENT TREATMENT: WITHIN-TREATMENT EFFECTS ON CRAVINGS, SELF-EFFICACY, PSYCHIATRIC SYMPTOMS, IMPULSIVITY, AND MINDFULNESS. ADDICTION CONTINUES TO BE A MAJOR PUBLIC HEALTH CONCERN, AND RATES OF RELAPSE FOLLOWING CURRENTLY-AVAILABLE TREATMENTS REMAIN HIGH. THERE IS INCREASING INTEREST IN THE ADJUNCTIVE USE OF MINDFULNESS-BASED INTERVENTIONS, SUCH AS YOGA, TO IMPROVE TREATMENT OUTCOMES. THE CURRENT STUDY WAS A PRELIMINARY NATURALISTIC INVESTIGATION OF A NOVEL TRAUMA-INFORMED YOGA INTERVENTION IN AN INPATIENT TREATMENT PROGRAM FOR WOMEN WITH SUBSTANCE USE DISORDER (SUD). CHANGES AND DIFFERENCES IN SOMATIC SYMPTOMS, PSYCHIATRIC SYMPTOMS, AND PSYCHOLOGICAL MECHANISMS WERE EVALUATED IN WOMEN RECEIVING TREATMENT-AS-USUAL (N = 36) AND TREATMENT-AS-USUAL PLUS THE YOGA INTERVENTION (N = 42). FOR BOTH GROUPS, STATISTICALLY SIGNIFICANT WITHIN-SUBJECTS CHANGES WERE PRESENT FOR SOMATIC AND PSYCHIATRIC SYMPTOMS, CRAVINGS, SELF-EFFICACY, AND MULTIPLE FACETS OF IMPULSIVITY AND MINDFULNESS. COMPARED TO STANDARD TREATMENT ALONE, PARTICIPANTS IN THE TREATMENT PLUS YOGA CONDITION SIGNIFICANTLY IMPROVED IN RANGE OF MOTION AND THE LACK OF PREMEDITATION FACET OF IMPULSIVITY. ALTHOUGH MOST DOMAINS WERE NOT SELECTIVELY AFFECTED, THESE INITIAL WITHIN-TREATMENT FINDINGS IN THIS NATURALISTIC EVALUATION SUGGEST SOME PROMISE FOR ADJUNCTIVE YOGA AND A NEED FOR FURTHER EVALUATION, ESPECIALLY USING LARGER SAMPLES AND LONGER TERM FOLLOW-UP. 2021 8 1291 26 GROUP ACUPUNCTURE THERAPY WITH YOGA THERAPY FOR CHRONIC NECK, LOW BACK, AND OSTEOARTHRITIS PAIN IN SAFETY NET SETTING FOR AN UNDERSERVED POPULATION: DESIGN AND RATIONALE FOR A FEASIBILITY PILOT. CHRONIC PAIN IS PREVALENT IN THE UNITED STATES, WITH IMPACT ON PHYSICAL AND PSYCHOLOGICAL FUNCTIONING AS WELL AS LOST WORK PRODUCTIVITY. MINORITY AND LOWER SOCIOECONOMIC POPULATIONS HAVE INCREASED PREVALENCE OF CHRONIC PAIN WITH LESS ACCESS TO PAIN CARE, POORER OUTCOMES, AND HIGHER RISK OF FATAL OPIOID OVERDOSE. ACUPUNCTURE THERAPY IS EFFECTIVE IN TREATING CHRONIC PAIN CONDITIONS INCLUDING CHRONIC LOW BACK PAIN, NECK PAIN, SHOULDER PAIN, AND KNEE PAIN FROM OSTEOARTHRITIS. ACUPUNCTURE THERAPY, INCLUDING GROUP ACUPUNCTURE, IS FEASIBLE AND EFFECTIVE, AND SPECIFICALLY SO FOR UNDERSERVED AND DIVERSE POPULATIONS AT RISK FOR HEALTH OUTCOME DISPARITIES. ACUPUNCTURE THERAPY ALSO ENCOURAGES PATIENT ENGAGEMENT AND ACTIVATION. AS CHRONIC PAIN IMPROVES, THERE IS A NATURAL PROGRESSION TO WANT AND NEED TO INCREASE ACTIVITY AND MOVEMENT RECOVERY. DIVERSE MOVEMENT APPROACHES ARE IMPORTANT FOR IMPROVING RANGE OF MOTION, MAINTAINING GAINS, STRENGTHENING, AND PROMOTING PATIENT ENGAGEMENT AND ACTIVATION. YOGA THERAPY IS AN ACTIVE THERAPY WITH PROVEN BENEFIT IN MUSCULOSKELETAL PAIN DISORDERS AND PAIN ASSOCIATED DISABILITY. THE AIM OF THIS QUASI-EXPERIMENTAL PILOT FEASIBILITY TRIAL IS TO TEST THE BUNDLING OF THESE 2 EFFECTIVE CARE OPTIONS FOR CHRONIC PAIN, TO INFORM BOTH THE DESIGN FOR A LARGER RANDOMIZED PRAGMATIC EFFECTIVENESS TRIAL AS WELL AS IMPLEMENTATION STRATEGIES ACROSS UNDERSERVED SETTINGS. 2020 9 1495 29 INTERVENTION PROTOCOL FOR INVESTIGATING YOGA IMPLEMENTED DURING CHEMOTHERAPY. OBJECTIVE: FATIGUE AND OTHER TREATMENT-RELATED SYMPTOMS ARE CRITICAL THERAPEUTIC TARGETS FOR IMPROVING QUALITY OF LIFE IN PATIENTS WITH COLORECTAL CANCER DURING CHEMOTHERAPY. YOGA IS A PROMISING INTERVENTION FOR IMPROVING THESE THERAPEUTIC TARGETS AND HAS BEEN PRIMARILY INVESTIGATED IN THE GROUP-CLASS FORMAT, WHICH IS LESS FEASIBLE FOR CANCER PATIENTS WITH HIGH SYMPTOM BURDEN TO ATTEND. THUS, WE DEVELOPED A PROTOCOL FOR IMPLEMENTING YOGA INDIVIDUALLY IN THE CLINIC AMONG PATIENTS RECEIVING CHEMOTHERAPY. METHODS: WE FOLLOWED RECOMMENDED DOMAINS FOR DEVELOPING A YOGA PROTOCOL TO BE USED IN AN EFFICACY TRIAL. THESE RECOMMENDATIONS INCLUDE CONSIDERATION TO THE STYLE, DELIVERY, COMPONENTS OF THE INTERVENTION, DOSE, SPECIFIC CLASS SEQUENCES, FACILITATION OF HOME PRACTICE, MEASUREMENT OF INTERVENTION FIDELITY, SELECTION OF INSTRUCTORS, AND DEALING WITH MODIFICATIONS. THE INTERVENTION PROTOCOL WAS DEVELOPED BY AN INTERDISCIPLINARY TEAM. PROTOCOL: YOGA SKILLS TRAINING (YST) CONSISTS OF FOUR 30-MINUTE IN-PERSON SESSIONS AND WAS IMPLEMENTED WHILE IN THE CHAIR DURING CHEMOTHERAPY INFUSIONS FOR COLORECTAL CANCER WITH RECOMMENDED DAILY HOME PRACTICE FOR EIGHT WEEKS. THERAPEUTIC GOALS OF THE YST ARE TO REDUCE FATIGUE, CIRCADIAN DISRUPTION, AND PSYCHOLOGICAL DISTRESS. ELEMENTS OF THE YST ARE AWARENESS MEDITATION, GENTLE SEATED MOVEMENT, BREATHING PRACTICE, AND RELAXATION MEDITATION. ATTENTION, COMFORT, AND EASE ARE ALSO HIGHLIGHTED. CONCLUSION: THIS DESCRIPTION OF A PROTOCOL FOR INTEGRATING YOGA WITH CONVENTIONAL CANCER TREATMENT WILL INFORM FUTURE STUDY DESIGNS AND CLINICAL PRACTICE. THE DESIGN OF THE YST IS NOVEL BECAUSE IT IMPLEMENTS YOGA-MOST COMMONLY STUDIED WHEN TAUGHT TO GROUPS OUTSIDE OF THE CLINICAL SETTING- INDIVIDUALLY DURING CLINICAL CARE. 2016 10 91 38 A MULTICOMPONENT YOGA-BASED, BREATH INTERVENTION PROGRAM AS AN ADJUNCTIVE TREATMENT IN PATIENTS SUFFERING FROM GENERALIZED ANXIETY DISORDER WITH OR WITHOUT COMORBIDITIES. OBJECTIVES: THE AIM OF THIS STUDY IS TO EVALUATE THE EFFICACY AND TOLERABILITY OF SUDARSHAN KRIYA YOGA (SKY) COURSE IN GENERALIZED ANXIETY DISORDER (GAD) OUTPATIENTS, WHO AFTER EIGHT WEEKS OF AN APPROPRIATE DOSE OF TRADITIONAL THERAPY HAD NOT YET ACHIEVED REMISSION. SUBJECTS: THE ADULT PARTICIPANTS (18-65 YEARS) WERE OUTPATIENTS WITH A PRIMARY DIAGNOSIS OF GAD WITH OR WITHOUT COMORBIDITIES ON THE MINI-INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW (MINI). PARTICIPANTS HAD A MINIMUM OF EIGHT WEEKS STANDARD TREATMENT WITH AN APPROPRIATE DOSE OF A STANDARD PRESCRIPTION ANXIOLYTIC, A CLINICIAN GLOBAL IMPRESSION-SEVERITY (CGI-S) SCORE OF 5-7, A HAMILTON ANXIETY SCALE (HAM-A) TOTAL SCORE >/=20 INCLUDING A SCORE OF >2 ON THE ANXIOUS MOOD AND TENSION ITEMS. MATERIALS AND METHODS: FORTY-ONE PATIENTS WERE ENROLLED IN AN OPEN-LABEL TRIAL OF THE SKY COURSE AS AN ADJUNCT TO STANDARD TREATMENT OF GAD AT THE START CLINIC FOR MOOD AND ANXIETY DISORDERS, A TERTIARY CARE MOOD AND ANXIETY DISORDER CLINIC IN TORONTO. THE SKY COURSE WAS ADMINISTERED OVER FIVE DAYS (22 H TOTAL). SUBJECTS WERE ENCOURAGED TO PRACTICE THE YOGA BREATHING TECHNIQUES AT HOME FOR 20 MIN PER DAY AFTER THE COURSE AND WERE OFFERED GROUP PRACTICE SESSIONS FOR 2 H ONCE A WEEK LED BY CERTIFIED YOGA INSTRUCTORS. THE PRIMARY OUTCOME MEASURE WAS THE MEAN CHANGE FROM PRE-TREATMENT ON THE HAM-A SCALE. PSYCHOLOGICAL MEASURES WERE OBTAINED AT BASELINE AND FOUR WEEKS AFTER COMPLETING THE INTERVENTION. RESULTS: THIRTY-ONE PATIENTS COMPLETED THE PROGRAM (MEAN AGE 42.6 +/- 13.3 YEARS). AMONG COMPLETERS, SIGNIFICANT REDUCTIONS OCCURRED IN THE PRE- AND POST-INTERVENTION MEAN HAM-A TOTAL SCORE (T=4.59; P<0.01) AND PSYCHIC SUBSCALE (T=5.00; P65%) EXPERTS SUGGESTED SUKSMAVYAYAMA SHOULD BE INCLUDED. FIVE OUT OF NINE EXPERTS OPINED THAT TRAINING WITH 10 SESSIONS (OVER 2 WEEKS) IS RATHER SHORT. ALL EXPERTS OPINED THAT THE MODULE IS EASY TO TEACH, LEARN AND PRACTICE. AT THE PILOT STAGE, THE FIVE PATIENTS WHO COMPLETED THE MODULE REPORTED MORE THAN 80% SATISFACTION ABOUT THE YOGA PRACTICES AND HOW THE YOGA WAS TAUGHT. SEVERITY OF DEPRESSION SUBSTANTIALLY REDUCED AT BOTH 1 AND 3 MONTHS FOLLOW-UP. CONCLUSION: THE DEVELOPED COMPREHENSIVE YOGA THERAPY MODULE WAS VALIDATED BY EXPERTS IN THE FIELD AND WAS FOUND TO BE FEASIBLE AND USEFUL IN PATIENTS WITH DEPRESSION. 2013 15 135 22 A PRELIMINARY INVESTIGATION OF THE EFFECTS OF ONE YOGA SESSION FOR SERVICE RECIPIENTS IN A BEHAVIORAL HEALTH INTENSIVE OUTPATIENT PROGRAM. THIS WAS AN INVESTIGATION OF THE FEASIBILITY AND EFFECTIVENESS OF A BRIEF YOGA INTERVENTION (ONE SESSION) WITHIN AN INTENSIVE OUTPATIENT PROGRAM (IOP) FOR SERVICE RECIPIENTS DIAGNOSED WITH VARIOUS PSYCHIATRIC DISORDERS. PARTICIPANTS (N=26) COMPLETED THE TORONTO MINDFULNESS SCALE (TMS) AND THE POSITIVE AND NEGATIVE AFFECT SCHEDULE (PANAS). DATA WAS COLLECTED BEFORE AND AFTER ONE YOGA SESSION AND FOLLOW-UP DATA WAS COLLECTED VIA MAIL AFTER DISCHARGE FROM THE IOP. SCORES INDICATED THAT NEGATIVE AFFECT SIGNIFICANTLY DECREASED AND POSITIVE AFFECT SIGNIFICANTLY INCREASED FROM PRE TO POST YOGA SESSION. MINDFULNESS SCORES SIGNIFICANTLY INCREASED FROM PRE TO POST YOGA SESSION. THOUGH THE RESULTS OF THIS STUDY SUPPORTED THAT A YOGA INTERVENTION IS BOTH FEASIBLE AND EFFECTIVE WITHIN AN IOP, COLLECTION OF FOLLOW-UP DATA AFTER DISCHARGE VIA MAIL WAS NOT AS FEASIBLE. THE RESULTS OF THIS PRELIMINARY INVESTIGATION SUPPORT A LARGER AND LONGITUDINAL STUDY TO FURTHER EXAMINE YOGA AS A TREATMENT MODALITY WITH THIS CLINICAL POPULATION. 2018 16 503 34 COMMUNITY-BASED YOGA FOR WOMEN UNDERGOING SUBSTANCE USE DISORDER TREATMENT: A DESCRIPTIVE STUDY. BACKGROUND: WOMEN WITH SUBSTANCE USE DISORDERS (SUD) RECEIVE MEDICATION-ASSISTED TREATMENT (MAT) WITH BEHAVIORAL INTERVENTIONS AND COUNSELING FOR RECOVERY. EVIDENCE SUPPORTS THE USE OF YOGA FOR SUD; HOWEVER FEW STUDIES SPECIFICALLY FEATURE WOMEN. OBJECTIVES: COMMUNITY-BASED YOGA MAY ADD TO HEALTH PROMOTION THROUGH PREFERABLE PHYSICAL ACTIVITY FOR WOMEN IN RECOVERY. THE AIMS OF THIS STUDY ARE TO EXPLORE DEMOGRAPHICS AND QUANTITATIVE MEASURES RELEVANT TO RECOVERY AND CAPTURE AND UNDERSTAND THE SUBJECTIVE EXPERIENCE OF ONE SESSION OF YOGA. STUDY DESIGN: THE STUDY DESIGN INVOLVES DESCRIPTIVE/CROSS-SECTIONAL. METHODOLOGY: WOMEN IN AN INPATIENT SUD CENTER ATTENDING WEEKLY OPTIONAL OFF-SITE YOGA FOR RECOVERY WERE RECRUITED TO CAPTURE FIRST-TIME ATTENDANCE. SURVEY DATA INCLUDED MEDICAL OUTCOMES SURVEY 12-ITEM SHORT-FORM (SF-12), TORONTO MINDFULNESS SCALE (TMS), AND BRIEF RESILIENCE SCALE (BRS), DEMOGRAPHICS, AND NARRATIVE REFLECTIONS. RECRUITMENT OPPORTUNITIES OCCURRED WEEKLY DURING ONGOING HOUR-LONG CLASSES. RESULTS: TWENTY-NINE WOMEN (AVERAGE AGE 36.6) WITH PRIMARILY OPIATE-BASED ADDICTIONS COMPLETED SURVEYS. SF-12 WAS BELOW THE NORMATIVE VALUE OF 50 FOR BOTH SUBSCALES. BRS SCORES SHOWED AVERAGES ON THE LOW END OF NORMAL RESILIENCY. THE FREQUENCY OF RESPONSES TO WRITING PROMPTS CONFIRMED PHYSICAL AND MENTAL WELL-BEING THROUGH YOGA INTERVENTION. WOMEN SHARED POTENTIAL RELAPSE PREVENTION SPECIFICALLY ATTRIBUTED TO THE MINDFULNESS COMPONENT OF THE INTERVENTION. CONCLUSION: THE SF-12, BRS, AND TMS ARE BRIEF, VALID, AND RELIABLE AND CAN BE EASILY INCORPORATED IN CLINICAL PRACTICE OR FUTURE RESEARCH. SUBOPTIMAL SF-12 SCORES WERE FOUND IN WOMEN WITH SUD AND, THEREFORE IMPORTANT TO NOTE IN THE CONTEXT OF RECOVERY TO OPTIMIZE TREATMENT. SUBJECTIVE REPORTS FROM THE PARTICIPANTS FIND COMMUNITY-BASED YOGA AN ENJOYABLE AND BENEFICIAL TYPE OF PHYSICAL ACTIVITY. YOGA MAY BE A VIABLE OPTION FOR COMPREHENSIVE MIND-BODY INTERVENTION FOR THIS POPULATION. 2021 17 420 33 BRIDGING BODY AND MIND: CASE SERIES OF A 10-WEEK TRAUMA-INFORMED YOGA PROTOCOL FOR VETERANS. THIS CASE SERIES EXPLORED THE FEASIBILITY AND PRELIMINARY EFFICACY OF THERAPEUTIC YOGA AS A COMPLEMENTARY FORM OF TREATMENT FOR COMBAT-RELATED TRAUMA. THE SERIES RECRUITED FOR AND IMPLEMENTED A 10-WEEK TRAUMA-INFORMED YOGA PROTOCOL FOR VETERANS IN AN INTERPROFESSIONAL COMMUNITY HEALTH TREATMENT SETTING. PARTICIPANTS WERE ENROLLED IN A SERIES OF 90-MINUTE THERAPEUTIC YOGA CLASSES ADAPTED TO BE TRAUMA-INFORMED. FEASIBILITY WAS MEASURED BY RECRUITMENT, RETENTION, AND LEVEL OF PARTICIPATION IN THE STUDY. PRELIMINARY EFFICACY WAS EXPLORED VIA THE POSTTRAUMATIC STRESS DISORDER CHECKLIST, SCALE OF BODY CONNECTION, PROMIS-29, PROMIS ALCOHOL USE, PROMIS SUBSTANCE USE, DIFFICULTIES IN EMOTIONAL REGULATION SCALE, AND SELF-COMPASSION SCALE-SHORT FORM. ALL MEASURES WERE ADMINISTERED AT BASELINE, WEEK 5, WEEK 10, AND AT A 5-WEEK FOLLOW-UP. A QUALITATIVE FEASIBILITY QUESTIONNAIRE WAS ADMINISTERED WEEKLY AND AT THE 5-WEEK FOLLOW-UP TO ASSESS BARRIERS AND MOTIVATORS FOR HOME PRACTICE AND TO COLLECT FEEDBACK ABOUT SESSION CONTENT. RECRUITMENT CHALLENGES RESULTED IN ONLY SEVEN INTERESTED INDIVIDUALS. FOUR PARTICIPANTS (THREE MALES, ONE FEMALE) WERE SUCCESSFULLY ENROLLED IN THE STUDY AFTER SEVEN PHONE SCREENINGS AND FIVE IN-PERSON INTERVIEWS. THE FOUR ENROLLED CLIENTS HAD A 100% FOLLOW-UP RETENTION RATE, REPORTED NO ADVERSE EVENTS, AND ON AVERAGE PARTICIPATED IN 85% OF CLASSES. CLINICALLY SIGNIFICANT ENHANCEMENTS WERE OBSERVED ON TRAUMA- AND BODY CONNECTION-RELATED SCALES FOR THREE PARTICIPANTS FROM BASELINE TO FOLLOW-UP. QUALITATIVE DATA REVEALED THAT MOTIVATORS TO PRACTICE INCLUDE IN-SESSION PHILOSOPHICAL DISCUSSIONS BASED ON PSYCHOLOGICAL THEMES; BREATHWORK; MINDFULNESS; AND PHYSICAL, SOCIAL, WORK/ACADEMIC, AND MENTAL HEALTH IMPACT. BARRIERS INCLUDED MOTIVATION, TIME, AND LOCATION. IMPORTANT THEMES EMERGED RELATED TO CULTURAL CONSIDERATIONS FOR VETERANS. ALTHOUGH THIS 10-WEEK TRAUMA-INFORMED PROTOCOL FACED CHALLENGES TO RECRUITMENT, RETENTION AND PARTICIPATION WERE HIGH. EFFICACY MEASURES YIELDED PROMISING RESULTS FOR REDUCING TRAUMA-RELATED SYMPTOMS. 2019 18 16 33 "SMOKING DOES NOT GO WITH YOGA:" A QUALITATIVE STUDY OF WOMEN'S PHENOMENOLOGICAL PERCEPTIONS DURING YOGA AND SMOKING CESSATION. INTRODUCTION: SMOKING CESSATION IS OFTEN ACCOMPANIED BY WITHDRAWAL SYMPTOMS, CIGARETTE CRAVING, INCREASED NEGATIVE AFFECT, AND INCREASED EXPERIENCE OF STRESS. BECAUSE YOGA HAS BEEN SHOWN TO REDUCE STRESS AND NEGATIVE AFFECT, IT MAY BE AN EFFECTIVE AID TO SMOKING CESSATION. THE OBJECTIVE OF THIS STUDY WAS TO EXAMINE WOMEN'S PHENOMENOLOGICAL EXPERIENCES OF VINYASA YOGA AS PART OF A SMOKING CESSATION PROGRAM. METHODS: FOCUS GROUPS WERE CONDUCTED POST-INTERVENTION WITH WOMEN (N = 20) WHO PARTICIPATED IN A PILOT RANDOMIZED CONTROLLED TRIAL OF YOGA AS A COMPLEMENTARY THERAPY FOR SMOKING CESSATION. THE 8-WEEK VINYASA YOGA INTERVENTION INCLUDED TWICE WEEKLY 60-MINUTE CLASSES THAT INVOLVED BREATHING EXERCISES, POSTURES (ASANAS), AND RELAXATION TECHNIQUES. FOCUS GROUPS WERE AUDIO RECORDED AND TRANSCRIBED. THEMATIC ANALYSIS FOCUSED ON DESCRIPTIONS OF YOGA, BREATHING, AND BODILY SENSATIONS INCLUDING CIGARETTE CRAVING. RESULTS: FOCUS GROUP PARTICIPANTS DESCRIBED VINYASA YOGA AS PHYSICALLY CHALLENGING. MOST REPORTED DELIBERATE USE OF YOGIC BREATHING TO COPE WITH CIGARETTE CRAVING AND STRESS. OTHER PERCEIVED EFFECTS INCLUDED RELAXATION AND AN INCREASED SENSE OF BODY AWARENESS AND WELLBEING. CONCLUSIONS: PARTICIPANTS VIEWED YOGA AS POSITIVE AND POTENTIALLY HELPFUL FOR QUITTING SMOKING. YOGA MAY BE AN EFFECTIVE ADJUNCT FOR SMOKING CESSATION. 2016 19 583 30 DESIGNING, VALIDATION AND FEASIBILITY OF A YOGA-BASED INTERVENTION FOR ELDERLY. CONTEXT: AGEING IS AN UNAVOIDABLE FACET OF LIFE. YOGIC PRACTICES HAVE BEEN REPORTED TO PROMOTE HEALTHY AGING. PREVIOUS STUDIES HAVE USED EITHER YOGA THERAPY INTERVENTIONS DERIVED FROM A PARTICULAR SCHOOL OF YOGA OR HAVE TESTED SPECIFIC YOGIC PRACTICES LIKE MEDITATION. AIMS: THIS STUDY REPORTS THE DEVELOPMENT, VALIDATION AND FEASIBILITY OF A YOGA-BASED INTERVENTION FOR ELDERLY WITH OR WITHOUT MILD COGNITIVE IMPAIRMENT. SETTINGS AND DESIGN: THE STUDY WAS CONDUCTED AT THE ADVANCED CENTRE FOR YOGA, NATIONAL INSTITUTE FOR MENTAL HEALTH AND NEUROSCIENCES, BANGALORE. THE MODULE WAS DEVELOPED, VALIDATED, AND THEN PILOT-TESTED ON VOLUNTEERS. MATERIALS AND METHODS: THE FIRST PART OF THE STUDY CONSISTED OF DESIGNING OF A YOGA MODULE BASED ON TRADITIONAL AND CONTEMPORARY YOGIC LITERATURE. THIS YOGA MODULE ALONG WITH THE THREE CASE VIGNETTES OF ELDERLY WITH COGNITIVE IMPAIRMENT WERE SENT TO 10 YOGA EXPERTS TO HELP DEVELOP THE INTENDED YOGA-BASED INTERVENTION. IN THE SECOND PART, THE FEASIBILITY OF THE DEVELOPED YOGA-BASED INTERVENTION WAS TESTED. RESULTS: EXPERTS (N=10) OPINED THE YOGA-BASED INTERVENTION WILL BE USEFUL IN IMPROVING COGNITION IN ELDERLY, BUT WITH SOME MODIFICATIONS. FREQUENT SUPERVISED YOGA SESSIONS, REGULAR FOLLOW-UPS, ADDITION/DELETION/MODIFICATIONS OF YOGA POSTURES WERE SOME OF THE SUGGESTIONS. TEN ELDERLY CONSENTED AND EIGHT COMPLETED THE PILOT TESTING OF THE INTERVENTION. ALL OF THEM WERE ABLE TO PERFORM MOST OF THE SUKSMAVYAYAMA, PRANAYAMA AND NADANUSANDHANA (MEDITATION) TECHNIQUE WITHOUT DIFFICULTY. SOME OF THE PARTICIPANTS (N=3) EXPERIENCED DIFFICULTY IN PERFORMING POSTURES SEATED ON THE GROUND. MOST OF THE OLDER ADULTS EXPERIENCED DIFFICULTY IN REMEMBERING AND COMPLETING ENTIRE SEQUENCE OF YOGA-BASED INTERVENTION INDEPENDENTLY. CONCLUSIONS: THE YOGA BASED INTERVENTION IS FEASIBLE IN THE ELDERLY WITH COGNITIVE IMPAIRMENT. TESTING WITH A LARGER SAMPLE OF OLDER ADULTS IS WARRANTED. 2013 20 2039 50 TESTING THE EFFICACY OF YOGA AS A COMPLEMENTARY THERAPY FOR SMOKING CESSATION: DESIGN AND METHODS OF THE BREATHEASY TRIAL. INTRODUCTION: SMOKERS TRYING TO QUIT ENCOUNTER MANY CHALLENGES INCLUDING NICOTINE WITHDRAWAL SYMPTOMS, CIGARETTE CRAVING, INCREASED STRESS AND NEGATIVE MOOD AND CONCERN REGARDING WEIGHT GAIN. THESE PHENOMENA MAKE IT DIFFICULT TO SUCCESSFULLY QUIT SMOKING. STUDIES IN NON-SMOKING POPULATIONS SHOW THAT YOGA REDUCES STRESS AND NEGATIVE MOOD AND IMPROVES WEIGHT CONTROL. BY INCREASING MINDFULNESS WE ANTICIPATE THAT YOGA MAY ALSO IMPROVE SMOKERS' ABILITY TO COPE WITH THE NEGATIVE SYMPTOMS ASSOCIATED WITH QUITTING. YOGA MAY ALSO IMPROVE COGNITIVE DELIBERATION WHICH IS NEEDED TO MAKE EFFECTIVE CHOICES AND AVOID SMOKING IN TEMPTING SITUATIONS. METHODS/DESIGN: THE BREATHEASY STUDY IS A RIGOROUS, RANDOMIZED CONTROLLED CLINICAL TRIAL EXAMINING THE EFFICACY OF IYENGAR YOGA AS A COMPLEMENTARY THERAPY TO COGNITIVE-BEHAVIORAL THERAPY FOR SMOKING CESSATION. ALL PARTICIPANTS ARE GIVEN AN 8-WEEK PROGRAM OF SMOKING CESSATION CLASSES, AND ARE RANDOMIZED TO EITHER TWICE WEEKLY YOGA (YOGA) OR TWICE-WEEKLY HEALTH AND WELLNESS CLASSES WHICH SERVE AS A CONTROL FOR CONTACT AND PARTICIPANT BURDEN (CTL). ASSESSMENTS ARE CONDUCTED AT BASELINE, 8 WEEKS, 3, 6, AND 12 MONTHS OF FOLLOW-UP. THE PRIMARY OUTCOME IS PROLONGED ABSTINENCE USING AN INTENTION-TO-TREAT APPROACH. MULTIPLE INTERNAL AND EXTERNAL AUDITS USING BLIND DATA COLLECTION ARE EMPLOYED TO ENSURE TREATMENT FIDELITY AND RELIABILITY OF STUDY RESULTS. TO UNDERSTAND WHY YOGA MAY BE MORE EFFECTIVE THAN CTL, WE WILL EXAMINE THE MECHANISMS OF ACTION (I.E., MEDIATORS) UNDERLYING INTERVENTION EFFICACY. WE WILL EXAMINE THE MAINTENANCE OF YOGA PRACTICE AND SMOKING STATUS AT EACH FOLLOW-UP. FOCUS GROUPS AND INTERVIEWS WILL BE USED TO ENRICH OUR UNDERSTANDING OF THE RELATIONSHIP OF YOGA PRACTICE AND SMOKING ABSTINENCE. CONCLUSIONS: THIS STUDY WILL PROVIDE A STRINGENT TEST OF THE RELATIVE EFFICACY OF YOGA COMPARED TO A CONDITION THAT CONTROLS FOR CONTACT TIME AND ATTENTION. THE USE OF MIXED METHODOLOGY ALSO PROVIDES THE OPPORTUNITY TO VALIDATE EXISTING KNOWLEDGE ABOUT YOGA AND HELPS TO EXPLORE NEW THEMES FOR FUTURE MINDFULNESS AND YOGA RESEARCH. 2014